Neurocrine Biosciences
NBIX
#1391
Rank
$12.70 B
Marketcap
$125.51
Share price
-1.18%
Change (1 day)
13.84%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2024 : $1.22 Billion USD

According to Neurocrine Biosciences 's latest financial reports the company has $1.22 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$1.03 B4.28%
2022-12-31$0.98 B39.08%
2021-12-31$0.71 B-11.2%
2020-12-31$0.80 B19.46%
2019-12-31$0.67 B3.01%
2018-12-31$0.65 B26.16%
2017-12-31$0.51 B67.86%
2016-12-31$0.30 B-18.95%
2015-12-31$0.37 B95.65%
2014-12-31$0.19 B32.98%
2013-12-31$0.14 B-15.76%
2012-12-31$0.17 B34.01%
2011-12-31$0.12 B1.76%
2010-12-31$0.12 B137.29%
2009-12-31$53.46 M-33.56%
2008-12-31$80.47 M-55.14%
2007-12-31$0.17 B-1.76%
2006-12-31$0.18 B-33.13%
2005-12-31$0.27 B-9.32%
2004-12-31$0.30 B-33.55%
2003-12-31$0.45 B85.19%
2002-12-31$0.24 B-23.52%
2001-12-31$0.31 B94.32%
2000-12-31$0.16 B80.76%
1999-12-31$91.1 M678.63%
1998-12-31$11.7 M-25.95%
1997-12-31$15.8 M39.82%
1996-12-31$11.3 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.80 B-34.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.76 B 43.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
$9.52 M-99.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.51 B 186.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.28 B 493.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.95 B 710.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.24 B-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.02 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA